3-(4-Hydroxy-3,5-dimethoxyphenyl)propanoic acid, 97+%, 5g

6-(Trifluoromethyl)imidazo[1,2-a]pyridine-3-carboxylic acid, 98+%, 100mg

(2-chloro-6-ethoxy-4-formylphenoxy)acetic acid, 1g

(1R,2R)-2-(1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)cyclohexane-1-carboxylic acid, 95+%, 50mg

Single-channel microliter pipette mLINE® variable, 0.5 to 10 µl, 1 piece

2,6-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 1g

TERT-BUTYL (2R,5R)-5-HYDROXY-2-METHYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 500mg

Methyl 2-chloroquinoline-6-carboxylate, 95.0%, 1g

6-(3-(Trifluoromethoxy)phenyl)nicotinaldehyde, 97%, 1g

(S)-Chroman-4-amine hydrochloride, 95.0%, 25g

3-((2-AMINO-3-CHLOROPYRIDIN-4-YL)THIO)-6-CHLOROPYRAZIN-2-AMINE, 95.0%, 1g

2-(1-Cyclopropylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 10g

1-(((Benzyloxy)carbonyl)amino)cyclohexanecarboxylic acid, 95.0%, 10g